Integra Lifesciences Holdings
IART· Manufacturing· Fiscal year ends in December
Mojdeh Poul is the CEO of Integra Lifesciences Holdings and was paid $9.4M in FY2025 (Dec).
Executives6
See all- 1Mojdeh PoulPresident and Chief Executive Officer and DirectorFY2025
- 2Lea KnightExecutive Vice President and Chief Financial OfficerFY2025
- 3Michael J. McBreenExecutive Vice President, President, Codman Specialty SurgicalFY2025
- 4Robert T. Davis, JrExecutive Vice President, President, Tissue TechnologiesFY2025
- 5Harvinder SinghExecutive Vice President, President, InternationalFY2025
- 6Jan De WitteFormer President and Chief Executive Officer and DirectorFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allIntegra Lifesciences Holdings paid its 6 named executives $18.8M in total in FY2025 (Dec). CEO Mojdeh Poul was paid $9.4M of that.
| Name | |||
|---|---|---|---|
| Mojdeh PoulPresident and Chief Executive Officer and Director | Not disclosed | Not disclosed | |
| Lea KnightExecutive Vice President and Chief Financial Officer | |||
| Michael J. McBreenExecutive Vice President, President, Codman Specialty Surgical | |||
| Robert T. Davis, JrExecutive Vice President, President, Tissue Technologies | |||
| Harvinder SinghExecutive Vice President, President, International | Not disclosed | ||
| Jan De WitteFormer President and Chief Executive Officer and Director |
of each named executive, from the Summary Compensation Table of each proxy.
Peers16
See allThe FY2025 (Dec) proxy of Integra Lifesciences Holdings names 16 peer companies for pay. Among Integra Lifesciences Holdings and these peers, CEO pay was 6th highest of 11 and total shareholder return was 10th highest of 11.
6th highest of 11in Integra Lifesciences Holdings and its pay peers, FY2025 (Dec) by CEO pay:
10th highest of 11in Integra Lifesciences Holdings and its pay peers, FY2025 (Dec) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board5
See all- Stuart M. EssigChair · 28 yr on the boardNot independentQuality (Chair)—Paid as an executive
- Christian S. SchadeDirector · 19 yr on the boardIndependentAudit (Chair), Finance (Chair)—Paid as an executive
- Shaundra D. ClayDirector · 4 yr on the boardIndependentAudit, Finance—Paid as an executive
- Renee W. LoDirector · 3 yr on the boardIndependentCompensation (Chair)—Paid as an executive
- Mojdeh PoulDirector · 0 yr on the boardNot independent—Paid as an executive
The board of the latest proxy (FY2025).
Activity
- PayDEF 14A
- PayDEF 14A
- PayIntegra Lifesciences Holdings President pay fell 96% to $282.7K. The stock fell 45% in FY2025 (Dec).DEF 14A
- PayDEF 14A
- PayDEF 14A
- PayDEF 14A
- PayDEF 14A
- PayDEF 14A
- Board3
- PayDEF 14A
- PayDEF 14A
- PayDEF 14A
- PayDEF 14A
- PayDEF 14A
- PayDEF 14A
- PayIntegra Lifesciences Holdings Former CFO pay fell 98% to $67.3K. The stock fell 22% in FY2023 (Dec).DEF 14A
- PayDEF 14A
- Board3
Filings6
See all| Proxy statement | DEF 14A | Apr 6, 2026 | FY2025 |
| Annual report | 10-K | Feb 26, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 4, 2025 | FY2024 |
| Annual report | 10-K | Feb 25, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 4, 2024 | FY2023 |
| Annual report | 10-K | Feb 28, 2024 | FY2023 |